You have 9 free searches left this month | for more free features.

City

Seoul (3)

Condition

Glioblastoma Multiforme (1)

Locally Advanced or Metastatic Pancreatic Cancer (1)

Metastatic Colorectal Cancer (1)

Overall Status

Recruiting (2)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

BeyondBio Inc. (3)

Collaborator

Intervention

bey1107 (3)

capecitabine (1)

gemcitabine (1)

temozolomide (1)

Study Documents

Intervention Type

combination product (3)

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

bey1107

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting

Glioblastoma Multiforme

BEY1107
Temozolomide

Seoul, Korea, Republic of

Seoul National University Hospital

Mar 13, 2023

Metastatic Colorectal Cancer Trial in Seoul (BEY1107, Capecitabine)

Recruiting

Metastatic Colorectal Cancer

BEY1107
Capecitabine

Seoul, Jongro-go, Korea, Republic of

Seoul National University Hospial

Oct 25, 2021

Locally Advanced or Metastatic Pancreatic Cancer Trial in Seoul (BEY1107, Gemcitabine)

Unknown status

Locally Advanced or Metastatic Pancreatic Cancer

BEY1107
Gemcitabine

Seoul, Korea, Republic of

Yonsei University Health System Severance Hospital

Jul 23, 2019